logo
OncTalk, LLC
OncTalk has moved to GRACE!.
Please migrate over and enjoy the new and
improved OncTalk through GRACE.
       
"As of April 30, 2008, all content from OncTalk will remain browsable and searchable, but no further content is being added to the post section or discussion forums. Post content has been moved to the website for GRACE (www.cancergrace.org). Please visit GRACE to provide your comments to posts and to initiate threads or add to the discussions in the forums on the GRACE site."

 

May 17, 2008


Email This Post
Print This Post

Significant Improvement in Progression-Free Survival in Advanced NSCLC with Alimta

   There’s a new post on a likely important trial in advanced NSCLC that I think will change the standard of care and lead to use of “maintenance” or early second line use of chemo immediately after first line chemo.  The details of the trial and my commentary are in the post on the GRACE website.



posted by Dr. West @ 2:53 pm link to this post

Comments are closed.

top of page Browse Complete Archives
Email This Post
Print This Post
About the Author:
Howard (Jack) West, MD
Dr. West serves as the Founder and Managing Member of OncTalk, LLC. He is a medical oncologist and Director of Medical Therapeutics for Thoracic Oncology at the Swedish Cancer Institute in Seattle, Washington.
Bio | C.V. | Contact



POLLS

Do you prefer to see generic names or trade names for drugs in our posts and comments?

View Results

Loading ... Loading ...

Disclaimer: The information provided at OncTalk is for informational purposes only. Howard West, MD is not providing medical advice, diagnosis or treatment and cannot replace the medical advice of your doctor or health care provider. (Full Disclaimer)
© 2006-07 OncTalk LLC. All rights reserved. Contact Webmaster




Disclaimer: The information provided at OncTalk is for informational purposes only. Howard West, MD is not providing medical advice, diagnosis or treatment and cannot replace the medical advice of your doctor or health care provider.